EUR 74.2
(0.41%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 4.70 EUR | 15.27% |
2022 | 4.06 EUR | -23.54% |
2021 | 5.31 EUR | 225.77% |
2020 | 1.63 EUR | -32.64% |
2019 | 2.42 EUR | -20.92% |
2018 | 3.06 EUR | 4.08% |
2017 | 2.94 EUR | 25.11% |
2016 | 2.35 EUR | 15.2% |
2015 | 2.04 EUR | -5.99% |
2014 | 2.17 EUR | 9.05% |
2013 | 1.99 EUR | 4.19% |
2012 | 1.91 EUR | -1.55% |
2011 | 1.94 EUR | -2.02% |
2010 | 1.98 EUR | 22.22% |
2009 | 1.62 EUR | -1.22% |
2008 | 1.64 EUR | -0.61% |
2007 | 1.65 EUR | 3.77% |
2006 | 1.59 EUR | -98.78% |
2005 | 130.00 EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | 2.01 EUR | 0.0% |
2023 Q2 | 2.72 EUR | 0.0% |
2023 Q4 | 1.97 EUR | 0.0% |
2023 FY | - EUR | 15.27% |
2022 Q4 | 2.25 EUR | 0.0% |
2022 FY | - EUR | -23.54% |
2022 Q2 | 1.81 EUR | 0.0% |
2021 FY | - EUR | 225.77% |
2021 Q2 | 3.06 EUR | 0.0% |
2021 Q4 | 2.25 EUR | 0.0% |
2020 Q2 | 1.27 EUR | 0.0% |
2020 Q4 | 0.35 EUR | 0.0% |
2020 FY | - EUR | -32.64% |
2019 Q2 | 1.10 EUR | 0.0% |
2019 FY | - EUR | -20.92% |
2019 Q4 | 1.32 EUR | 0.0% |
2018 Q2 | 1.33 EUR | 0.0% |
2018 FY | - EUR | 4.08% |
2018 Q4 | 1.73 EUR | 0.0% |
2017 Q4 | 1.73 EUR | 0.0% |
2017 Q2 | 1.21 EUR | 0.0% |
2017 FY | - EUR | 25.11% |
2016 Q4 | 1.21 EUR | 0.0% |
2016 Q2 | 1.14 EUR | 0.0% |
2016 FY | - EUR | 15.2% |
2015 FY | - EUR | -5.99% |
2015 Q4 | 0.99 EUR | 0.0% |
2015 Q2 | 1.05 EUR | 0.0% |
2014 Q4 | 1.31 EUR | 0.0% |
2014 Q2 | 0.86 EUR | 0.0% |
2014 FY | - EUR | 9.05% |
2013 FY | - EUR | 4.19% |
2013 Q2 | 0.84 EUR | 0.0% |
2013 Q4 | 1.14 EUR | 0.0% |
2012 FY | - EUR | -1.55% |
2012 Q2 | 0.48 EUR | 0.0% |
2012 Q4 | 0.50 EUR | 4.17% |
2012 Q3 | 0.48 EUR | 0.0% |
2012 Q1 | 0.48 EUR | 0.0% |
2011 Q2 | 0.48 EUR | 0.0% |
2011 Q1 | 0.48 EUR | 0.0% |
2011 Q3 | 0.48 EUR | 0.0% |
2011 Q4 | 0.48 EUR | 0.0% |
2011 FY | - EUR | -2.02% |
2010 Q2 | 0.47 EUR | 0.0% |
2010 Q3 | 0.47 EUR | 0.0% |
2010 Q4 | 0.48 EUR | 2.13% |
2010 FY | - EUR | 22.22% |
2010 Q1 | 0.47 EUR | 0.0% |
2009 FY | - EUR | -1.22% |
2009 Q1 | 0.38 EUR | 0.0% |
2009 Q4 | 0.47 EUR | 23.68% |
2009 Q3 | 0.38 EUR | 0.0% |
2009 Q2 | 0.38 EUR | 0.0% |
2008 Q1 | 0.37 EUR | 0.0% |
2008 FY | - EUR | -0.61% |
2008 Q4 | 0.38 EUR | 2.7% |
2008 Q3 | 0.37 EUR | 0.0% |
2008 Q2 | 0.37 EUR | 0.0% |
2007 Q2 | 0.37 EUR | 0.0% |
2007 Q1 | 0.37 EUR | 0.0% |
2007 FY | - EUR | 3.77% |
2007 Q4 | 0.37 EUR | 0.0% |
2007 Q3 | 0.37 EUR | 0.0% |
2006 Q2 | 0.32 EUR | 0.0% |
2006 FY | - EUR | -98.78% |
2006 Q1 | 0.32 EUR | 0.0% |
2006 Q3 | 0.32 EUR | 0.0% |
2006 Q4 | 0.37 EUR | 15.63% |
2005 Q4 | 0.32 EUR | 28.0% |
2005 FY | - EUR | 0.0% |
2005 Q1 | 0.25 EUR | 0.0% |
2005 Q2 | 0.25 EUR | 0.0% |
2005 Q3 | 0.25 EUR | 0.0% |
2004 Q4 | 0.25 EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Boiron SA | 2.06 EUR | -128.155% |
Laboratorios Farmaceuticos Rovi, S.A. | 3.20 EUR | -46.875% |
Valneva SE | -0.73 EUR | 743.836% |
AB Science S.A. | -0.20 EUR | 2450.0% |
Nanobiotix S.A. | -1.08 EUR | 535.185% |
PHAXIAM Therapeutics S.A. | -5.00 EUR | 194.0% |
Vivoryon Therapeutics N.V. | -1.12 EUR | 519.643% |
BioSenic S.A. | -0.21 EUR | 2338.095% |
ABIVAX Société Anonyme | -3.43 EUR | 237.026% |
Formycon AG | 4.76 EUR | 1.261% |